Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Cancer Cell
|
November 13, 2007
Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease
Emily K Thomas, Jose A Cancelas, Hee-Don Chae, et al.
Cancer Research
|
June 17, 2010
Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers
Kathryn G Roberts, Amanda M Smith, Fiona McDougall, et al.
The Journal of Experimental Medicine
|
September 19, 2007
The PP2A inhibitor SET regulates natural killer cell IFN-gamma production
Rossana Trotta, David Ciarlariello, Jessica Dal Col, et al.
JCI Insight
|
March 23, 2026
Extracellular vesicle miR-93-5p cargo regulates glomerular endothelial cell damage in Alport syndrome
Charmi Dedhia, Valentina Villani, Xiaogang Hou, et al.
Cancer Cell
|
November 16, 2005
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
Paolo Neviani, Ramasamy Santhanam, Rossana Trotta, et al.
Journal of the National Cancer Institute
|
May 15, 2015
Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy
Kishore B Challagundla, Petra M Wise, Paolo Neviani, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 10, 2009
Modulation of DNA methylation by a sesquiterpene lactone parthenolide
Zhongfa Liu, Shujun Liu, Zhiliang Xie, et al.
The Journal of Clinical Investigation
|
August 25, 2007
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia
Paolo Neviani, Ramasamy Santhanam, Joshua J Oaks, et al.
Blood
|
August 24, 2013
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias
Christopher J Walker, Joshua J Oaks, Ramasamy Santhanam, et al.
Cell
|
March 10, 2010
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts
Anna M Eiring, Jason G Harb, Paolo Neviani, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Cancer Cell
|
November 13, 2007
Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease
Emily K Thomas, Jose A Cancelas, Hee-Don Chae, et al.
Cancer Research
|
June 17, 2010
Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers
Kathryn G Roberts, Amanda M Smith, Fiona McDougall, et al.
The Journal of Experimental Medicine
|
September 19, 2007
The PP2A inhibitor SET regulates natural killer cell IFN-gamma production
Rossana Trotta, David Ciarlariello, Jessica Dal Col, et al.
JCI Insight
|
March 23, 2026
Extracellular vesicle miR-93-5p cargo regulates glomerular endothelial cell damage in Alport syndrome
Charmi Dedhia, Valentina Villani, Xiaogang Hou, et al.
Cancer Cell
|
November 16, 2005
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
Paolo Neviani, Ramasamy Santhanam, Rossana Trotta, et al.
Journal of the National Cancer Institute
|
May 15, 2015
Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy
Kishore B Challagundla, Petra M Wise, Paolo Neviani, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 10, 2009
Modulation of DNA methylation by a sesquiterpene lactone parthenolide
Zhongfa Liu, Shujun Liu, Zhiliang Xie, et al.
The Journal of Clinical Investigation
|
August 25, 2007
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia
Paolo Neviani, Ramasamy Santhanam, Joshua J Oaks, et al.
Blood
|
August 24, 2013
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias
Christopher J Walker, Joshua J Oaks, Ramasamy Santhanam, et al.
Cell
|
March 10, 2010
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts
Anna M Eiring, Jason G Harb, Paolo Neviani, et al.
Page
of 5